Keyphrases
Age-related Illnesses
25%
Antipsychotics
100%
Atypical Agents
25%
Atypical Antipsychotics
50%
B Cells
100%
Blood Glucose
25%
Blood Lipid Profile
25%
Cell Toxicity
100%
Central Obesity
25%
Clinical Features
25%
Clinical Problems
25%
Concentration Monitoring
25%
Dyslipidemia
25%
Extrapyramidal Side Effects
25%
Glucose Homeostasis
25%
Glucose Tolerance
25%
Hallucinations
25%
Increased Mortality
25%
Insulin
25%
Life Expectancy
25%
Mammalian Target of Rapamycin Signaling Pathway
50%
Medication-related Harm
25%
Metabolic Syndrome
100%
Obesity-related Hypertension
25%
Olanzapine
100%
Patients with Schizophrenia
25%
Reduced Toxicity
25%
Routine Monitoring
25%
Schizophrenia
25%
Scientific Expertise
25%
Stress Disorders
25%
Studentship
25%
Technical Expertise
25%
Through Effect
25%
University of Brighton
50%
Pharmacology, Toxicology and Pharmaceutical Science
Atypical Antipsychotics
50%
Clinical Feature
25%
Cytotoxicity
100%
Diseases
25%
Dyslipidemia
25%
Extrapyramidal Symptoms
25%
Hallucination
25%
Life Expectancy
25%
Mammalian Target of Rapamycin
50%
Metabolic Syndrome X
100%
Olanzapine
100%
Neuroscience
Atypical Antipsychotic
50%
Beta Cell
100%
Cytotoxicity
100%
Dyslipidemia
25%
Extrapyramidal Symptoms
25%
Hallucination
25%
Hypertension
25%
Mammalian Target of Rapamycin
50%
Olanzapine
100%